Mrassf1a-Pap, a Novel Methylation-Based Assay for the Detection of Cell-Free Fetal DNA in Maternal Plasma

被引:9
|
作者
van den Oever, Jessica M. E. [1 ]
Balkassmi, Sahila [1 ]
Segboer, Tim [1 ]
Verweij, E. Joanne [2 ]
van der Velden, Pieter A. [3 ]
Oepkes, Dick [2 ]
Bakker, Egbert [1 ]
Boon, Elles M. J. [1 ]
机构
[1] Leiden Univ, Med Ctr, LDGA, Dept Clin Genet, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
关键词
NONINVASIVE-PRENATAL-DIAGNOSIS; PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION; PLACENTAL EPIGENETIC SIGNATURE; RASSF1A GENE; HYPERMETHYLATED RASSF1A; PCR; POLYMORPHISMS; RELIABILITY; MARKERS; ORIGIN;
D O I
10.1371/journal.pone.0084051
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: RASSF1A has been described to be differentially methylated between fetal and maternal DNA and can therefore be used as a universal sex-independent marker to confirm the presence of fetal sequences in maternal plasma. However, this requires highly sensitive methods. We have previously shown that Pyrophosphorolysis-activated Polymerization (PAP) is a highly sensitive technique that can be used in noninvasive prenatal diagnosis. In this study, we have used PAP in combination with bisulfite conversion to develop a new universal methylation-based assay for the detection of fetal methylated RASSF1A sequences in maternal plasma. Methods: Bisulfite sequencing was performed on maternal genomic (g) DNA and fetal gDNA from chorionic villi to determine differentially methylated regions in the RASSF1A gene using bisulfite specific PCR primers. Methylation specific primers for PAP were designed for the detection of fetal methylated RASSF1A sequences after bisulfite conversion and validated. Results: Serial dilutions of fetal gDNA in a background of maternal gDNA show a relative percentage of similar to 3% can be detected using this assay. Furthermore, fetal methylated RASSF1A sequences were detected both retrospectively as well as prospectively in all maternal plasma samples tested (n = 71). No methylated RASSF1A specific bands were observed in corresponding maternal gDNA. Specificity was further determined by testing anonymized plasma from non-pregnant females (n = 24) and males (n = 21). Also, no methylated RASSF1A sequences were detected here, showing this assay is very specific for methylated fetal DNA. Combining all samples and controls, we obtain an overall sensitivity and specificity of 100% (95% CI 98.4%-100%). Conclusions: Our data demonstrate that using a combination of bisulfite conversion and PAP fetal methylated RASSF1A sequences can be detected with extreme sensitivity in a universal and sex-independent manner. Therefore, this assay could be of great value as an addition to current techniques used in noninvasive prenatal diagnostics.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Prenatal Diagnosis of β-thalassemia with Cell-free Fetal DNA in Maternal Plasma
    Zhao, Lijian
    Liang, Xuxia
    Huang, Haini
    Lan, Huihua
    Wu, Xin
    Wang, Chenhong
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (05): : 483 - 485
  • [22] Detection of Fetal Subchromosomal Abnormalities by Sequencing Circulating Cell-Free DNA from Maternal Plasma
    Zhao, Chen
    Tynan, John
    Ehrich, Mathias
    Hannum, Gregory
    McCullough, Ron
    Saldivar, Juan-Sebastian
    Oeth, Paul
    van den Boom, Dirk
    Deciu, Cosmin
    CLINICAL CHEMISTRY, 2015, 61 (04) : 608 - 616
  • [23] Detection of cell-free fetal DNA in maternal plasma using two types of compound markers
    Tan, Yu
    Zhang, Lin
    Bai, Peng
    Li, Zhilong
    Zhang, RanRan
    Yang, Fan
    Wang, Li
    Liang, Weibo
    ELECTROPHORESIS, 2021, 42 (9-10) : 1158 - 1167
  • [24] Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma
    Porreco, Richard P.
    Sekedat, Matthew
    Bombard, Allan
    Garite, Thomas J.
    Maurel, Kimberly
    Marusiak, Barbara
    Adair, David
    Bleich, April
    Combs, C. Andrew
    Kramer, Wayne
    Longo, Sherri
    Nageotte, Michael
    Samuel, Amber
    Vanderhoeven, Jeroen
    Buis, Jeff
    Jacobs, Kevin B.
    Stoerker, Jay
    JOURNAL OF MEDICAL SCREENING, 2020, 27 (01) : 1 - 8
  • [25] Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening
    Rink, Britton D.
    Stevens, Blair K.
    Norton, Mary E.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (01) : 17 - 19
  • [26] Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening
    Rink, Britton D.
    Stevens, Blair K.
    Norton, Mary E.
    OBSTETRICS AND GYNECOLOGY, 2022, 140 (01): : 121 - 131
  • [27] Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
    Wang, Eric
    Batey, Annette
    Struble, Craig
    Musci, Thomas
    Song, Ken
    Oliphant, Arnold
    PRENATAL DIAGNOSIS, 2013, 33 (07) : 662 - 666
  • [28] Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients
    Li, Dandan
    Li, Pengchang
    Wu, Jie
    Yi, Jie
    Dou, Yaling
    Guo, Xiuzhi
    Yin, Yicong
    Wang, Danchen
    Ma, Chaochao
    Qiu, Ling
    CLINICA CHIMICA ACTA, 2018, 484 : 81 - 86
  • [29] Designing a quantitative PCR assay for fetal RhD genotyping from maternal plasma derived cell-free fetal DNA (cffDNA)
    Parviainen, Suvi
    Veikkolainen, Ville
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 360 - 361
  • [30] Restriction Enzyme-Mediated Enhanced Detection of Circulating Cell-Free Fetal DNA in Maternal Plasma
    Tynan, John A.
    Mahboubi, Payam
    Cagasan, Lesley L.
    van den Boom, Dirk
    Ehrich, Mathias
    Oeth, Paul
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (04): : 382 - 389